Jennison Associates
CDMO

Jennison Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Jennison Associates’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,117,104
Closed -$13.8M – 646
2024
Q4 		$13.8M Buy
+1,117,104
New +$12.8M 0.01% 377
2024
Q1 		– Sell
-101,147
Closed -$657K – 642
2023
Q4 		$657K Sell
101,147
-2,169,738
-96% -$14M ﹤0.01% 541
2023
Q3 		$21.4M Sell
2,270,885
-820,959
-27% -$9.88M 0.02% 306
2023
Q2 		$43.2M Buy
3,091,844
+149,268
+5% +$2.54M 0.04% 209
2023
Q1 		$55.2M Buy
2,942,576
+13,412
+0.5% +$220K 0.05% 172
2022
Q4 		$40.3M Buy
2,929,164
+52,495
+2% +$804K 0.04% 218
2022
Q3 		$55M Buy
2,876,669
+1,005,100
+54% +$18.3M 0.05% 166
2022
Q2 		$28.6M Buy
1,871,569
+610,382
+48% +$9.03M 0.03% 262
2022
Q1 		$25.7M Buy
1,261,187
+291,906
+30% +$5.94M 0.02% 319
2021
Q4 		$28.3M Sell
969,281
-84,084
-8% -$2.41M 0.02% 303
2021
Q3 		$22.7M Buy
1,053,365
+242,318
+30% +$5.85M 0.01% 344
2021
Q2 		$20.8M Buy
811,047
+588,483
+264% +$12.6M 0.01% 363
2021
Q1 		$4.06M Buy
+222,564
New +$3.7M ﹤0.01% 491

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jennison Associates's CDMO Position: Q1 2025 in Review

Jennison Associates sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,117,104 shares — an estimated $13.8M sold.

Jennison Associates first reported a position in CDMO in Q1 2021 and held it in 13 quarters. The position peaked at $55.2M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Jennison Associates reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Jennison Associates sold 1,117,104 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $13.8M.
  • Jennison Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Jennison Associates's Avid Bioservices, Inc. Common Stock position peaked at $55.2M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Jennison Associates's 13F filing for Q1 2025, filed 5 May 2025.